🔗 Share this article

A shadow economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these profiles privately for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of members share comparison images, injection guides and claims of next-day UK delivery. Vendors market the substance there before directing customers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Voice Worries

However, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is worrisome and could result in individuals administering substances of uncertain source.

Several experts said the popularity for retatrutide could be connected to the rising price of licensed slimming products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, risking penalties, legal action or imprisonment.

Platform Response and Content Elimination

According to TikTok, the service has taken down violative material and prohibited related keywords and search suggestions. The organization stated it was dedicated to keeping the service safe and allocating resources in strengthening compliance measures.

Online Marketplace Operations

Research also found communities with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, populated with images of weight loss, glowing testimonials and step-by-step guides for mixing or administering at residence.

After moments of entering one group, a seller posted contact information, where most purchases take place. The seller provided an guidebook and promised shipping within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about body mass, health issues or previous experience.

Item Details and Pricing

Within these groups, posts show black plastic parcels with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how long a injector should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service stated it regularly monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they can’t verify. Even if the science behind retatrutide is valid, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her team has previously encountered individuals injured by personal administration from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to possibly significant health risks”.